NM_004385.5:c.645A>G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004385.5(VCAN):​c.645A>G​(p.Val215Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.374 in 1,613,894 control chromosomes in the GnomAD database, including 118,135 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.33 ( 8925 hom., cov: 32)
Exomes 𝑓: 0.38 ( 109210 hom. )

Consequence

VCAN
NM_004385.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.282

Publications

19 publications found
Variant links:
Genes affected
VCAN (HGNC:2464): (versican) This gene is a member of the aggrecan/versican proteoglycan family. The protein encoded is a large chondroitin sulfate proteoglycan and is a major component of the extracellular matrix. This protein is involved in cell adhesion, proliferation, proliferation, migration and angiogenesis and plays a central role in tissue morphogenesis and maintenance. Mutations in this gene are the cause of Wagner syndrome type 1. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2009]
VCAN Gene-Disease associations (from GenCC):
  • Wagner disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 5-83493828-A-G is Benign according to our data. Variant chr5-83493828-A-G is described in ClinVar as Benign. ClinVar VariationId is 259373.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.282 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.403 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VCANNM_004385.5 linkc.645A>G p.Val215Val synonymous_variant Exon 5 of 15 ENST00000265077.8 NP_004376.2 P13611-1A0A024RAQ9Q59FG9
VCANNM_001164097.2 linkc.645A>G p.Val215Val synonymous_variant Exon 5 of 14 NP_001157569.1 P13611-2A0A024RAL1Q6MZK8
VCANNM_001164098.2 linkc.645A>G p.Val215Val synonymous_variant Exon 5 of 14 NP_001157570.1 P13611-3A0A024RAP3
VCANNM_001126336.3 linkc.645A>G p.Val215Val synonymous_variant Exon 5 of 13 NP_001119808.1 P13611-4Q86W61

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VCANENST00000265077.8 linkc.645A>G p.Val215Val synonymous_variant Exon 5 of 15 1 NM_004385.5 ENSP00000265077.3 P13611-1

Frequencies

GnomAD3 genomes
AF:
0.331
AC:
50285
AN:
151934
Hom.:
8930
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.243
Gnomad AMI
AF:
0.441
Gnomad AMR
AF:
0.306
Gnomad ASJ
AF:
0.353
Gnomad EAS
AF:
0.0792
Gnomad SAS
AF:
0.234
Gnomad FIN
AF:
0.373
Gnomad MID
AF:
0.328
Gnomad NFE
AF:
0.407
Gnomad OTH
AF:
0.320
GnomAD2 exomes
AF:
0.322
AC:
80932
AN:
251278
AF XY:
0.325
show subpopulations
Gnomad AFR exome
AF:
0.240
Gnomad AMR exome
AF:
0.270
Gnomad ASJ exome
AF:
0.364
Gnomad EAS exome
AF:
0.0686
Gnomad FIN exome
AF:
0.376
Gnomad NFE exome
AF:
0.398
Gnomad OTH exome
AF:
0.356
GnomAD4 exome
AF:
0.379
AC:
554125
AN:
1461842
Hom.:
109210
Cov.:
63
AF XY:
0.376
AC XY:
273369
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.240
AC:
8036
AN:
33480
American (AMR)
AF:
0.279
AC:
12481
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.361
AC:
9446
AN:
26134
East Asian (EAS)
AF:
0.0545
AC:
2165
AN:
39698
South Asian (SAS)
AF:
0.244
AC:
21072
AN:
86256
European-Finnish (FIN)
AF:
0.375
AC:
20012
AN:
53416
Middle Eastern (MID)
AF:
0.331
AC:
1907
AN:
5768
European-Non Finnish (NFE)
AF:
0.411
AC:
457570
AN:
1111978
Other (OTH)
AF:
0.355
AC:
21436
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
23805
47610
71416
95221
119026
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13934
27868
41802
55736
69670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.331
AC:
50274
AN:
152052
Hom.:
8925
Cov.:
32
AF XY:
0.326
AC XY:
24212
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.243
AC:
10062
AN:
41468
American (AMR)
AF:
0.306
AC:
4676
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.353
AC:
1227
AN:
3472
East Asian (EAS)
AF:
0.0794
AC:
411
AN:
5178
South Asian (SAS)
AF:
0.234
AC:
1127
AN:
4822
European-Finnish (FIN)
AF:
0.373
AC:
3934
AN:
10552
Middle Eastern (MID)
AF:
0.322
AC:
94
AN:
292
European-Non Finnish (NFE)
AF:
0.407
AC:
27669
AN:
67966
Other (OTH)
AF:
0.318
AC:
673
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1695
3390
5086
6781
8476
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
496
992
1488
1984
2480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.382
Hom.:
21378
Bravo
AF:
0.322
Asia WGS
AF:
0.181
AC:
631
AN:
3478
EpiCase
AF:
0.403
EpiControl
AF:
0.400

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Wagner syndrome Benign:3
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Sep 21, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Vitreoretinopathy Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
9.8
DANN
Benign
0.75
PhyloP100
0.28
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4470745; hg19: chr5-82789647; COSMIC: COSV54104482; API